Navigation Links
FDA Approves New Type 2 Diabetes Drug
Date:8/1/2014

FRIDAY, Aug. 1, 2014 (HealthDay News) -- The U.S. Food and Drug Administration announced on Friday that it approved a new drug, Jardiance, to help fight type 2 diabetes.

Jardiance (empagliflozin) "can be used alone or added to existing treatment regimens to control blood sugar levels in the overall management of diabetes," Dr. Curtis Rosebraugh, director of the Office of Drug Evaluation II in the FDA's Center for Drug Evaluation and Research, said in an agency statement.

The FDA also recommended that Jardiance be used along with lifestyle changes, such as eating a healthy diet and exercising regularly. The combination of medication and lifestyle modification may improve blood sugar management for people with type 2 diabetes, they said.

Over 26 million Americans are currently affected by type 2 diabetes, which accounts for about 90 percent of cases of diabetes, according to the agency.

Jardiance, made by Connecticut-based Boehringer Ingelheim Pharmaceuticals, falls into the class of diabetes medicines known as "sodium glucose co-transporter 2 (SGLT2) inhibitors." These drugs work by stopping blood sugar, or glucose, from getting reabsorbed by the kidneys. That means that more glucose is excreted by the kidneys and blood sugar levels go down, the FDA explained. Other drugs in this class of medications include Invokana (canagliflozin) and Farxiga (dapagliflozin).

The agency said the safety and effectiveness of Jardiance was tested in seven clinical trials involving almost 4,500 people with type 2 diabetes. The studies showed that Jardiance improved blood sugar levels compared to a "dummy" placebo drug.

The drug has also been studied for use alongside other medications, such as metformin, sulfonylureas, pioglitazone (Actos) and insulin. The FDA stressed that it is ordering post-marketing studies on Jardiance, with a focus on any potential cardiovascular effects, as well as safety and effectiveness in children.

Jardianc
'/>"/>

Copyright©2014 ScoutNews,LLC.
All rights reserved  

Page: 1 2

Related medicine news :

1. FDA Approves Generic Versions of Plavix
2. FDA Approves Combo Shot for Meningitis, Hib in Kids
3. FDA Approves SonixGPS Needle Guidance Technology for Vascular Access Procedures
4. FDA Approves First New Weight-Loss Drug in More Than a Decade
5. FDA Approves 1st Pill to Help Prevent HIV Infection
6. FDA Approves 2nd New Weight-Loss Drug
7. FDA Approves Flu Vaccine for Coming Season
8. FDA Approves New Once-a-Day HIV Pill
9. FDA Approves New Type of Flu Vaccine
10. Environmental Protection Agency Approves MOMS by OdorXit as a Disinfectant
11. FDA Approves 1st Skin Patch to Combat Migraines
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Approves New Type 2 Diabetes Drug
(Date:3/1/2015)... 02, 2015 As residents and ... co-founders, Michael Burns and Carita Weaver, believe in ... working with the Southlake Chamber of Commerce, Carroll ... works recently launched a website for Southlake mayoral ... primary communications tool for Hill’s campaign, the website ...
(Date:3/1/2015)... 01, 2015 Adults who are not ... for term or universal policies can now use the ... best life insurance companies for single adults can now ... http://quotespros.com/life-insurance.html . , The rate plans that nationwide ... tied to a number of life protection policies. The ...
(Date:3/1/2015)... NY (PRWEB) March 01, 2015 The ... grown substantially over the past few weeks in two ... are actively filing claims, the Firm announces. , ... 7,713 cases in the Bergen County proceeding established for ... compared with a few weeks earlier, when 90 fewer ...
(Date:3/1/2015)... Theme and plugin developers from Pixel ... pack for Final Cut Pro X entitled Transccordion. , ... any FCPX editors project.” Said Christiana Austin, CEO of ... needed to easily drag and drop their accordion transition ... different controls over the parameters of this transition bundle ...
(Date:2/28/2015)... Heart diseases are on the rise in ... adult population and 5 percent of rural adult population ... percent of them require specialized investigation and treatment to ... diseases (CVD). , A division of Indian Business News ... titled “Indian Coronary Stent Market Forecast to 2019”. The ...
Breaking Medicine News(10 mins):Health News:Website Launched for Southlake, Texas Mayoral Candidate Laura Hill 2Health News:Best Life Insurance Companies for Single Adults Now Searchable at Insurance Website 2Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 2Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 3Health News:Bernstein Liebhard LLP Comments on Case List Growth in New Jersey Transvaginal Mesh Litigations, Where Firm Attorneys are Representing Hundreds 4Health News:Announcing a New Transition Pack from Pixel Film Studios, Transccordion for Final Cut Pro X 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 3
... help improve treatment for psychiatric problems , , MONDAY, ... have an increased risk of developing schizophrenia, depression, generalized ... new study that spanned more than three decades shows. ... persistent depression and anxiety, as well as an increased ...
... Dec. 1 Amanzi Tea ( www.amanzitea.com ), a unique tea ... Manhattan location opening Saturday, December 6th, it is offering free "amanzi ... on Saturdays, December 6th, 13th and 20th from noon until four. ... immune system with the onset of winter. , ...
... As part of the Dec. 1 observance of World AIDS Day, ... tested for HIV - the virus that causes AIDS. He also ... how it is prevented. , , ... or race, being tested for HIV is the only sure way ...
... CT can effectively assess coronary artery stenosis, according to ... in Leiden, The Netherlands. , The study consisted ... with 50% or more stenosis. 10,561 coronary artery segments ... sensitivity rate for detecting significant coronary artery stenosis in ...
... studies have shown that babies exposed to tobacco in ... weight and are at increased risk for sudden infant ... reveals that these babies are also less likely to ... whose mothers did not smoke during pregnancy. , Researchers ...
... Dec. 1 As President Bush seeks,to push through ... especially,adversely impact healthcare services and workplace safety, the California,Nurses ... web browsers to help "send Bush packing,", http://www.SendBushPacking.com . ... offers an interactive game highlighting some of the "midnight,rules" ...
Cached Medicine News:Health News:Low Childhood IQ Tied to Risk of Later Mental Disorders 2Health News:Amanzi Tea offers free, natural 'Flu Shots' to New Yorkers 2Health News:PA Department of Health Recognizes 20th Anniversary of World AIDS Day; Urges HIV Testing 2Health News:Newborns exposed to maternal smoking more irritable, difficult to soothe 2Health News:Citing 'Midnight Rules' to Erode Health and Safety, Nurses Unveil New Website to Send Bush Packing 2
(Date:2/27/2015)... 27, 2015 Roughly three-quarters of pharmacists ... substituting an interchangeable biosimilar for its branded biologic ... nonproprietary name, according to a survey published in ... Journal of Managed Care & Specialty Pharmacy (JMCP). ... of pharmacists would feel as confident if the ...
(Date:2/27/2015)... Feb. 27, 2015  Pharmacyclics, Inc. (NASDAQ: ... pre-clinical study published in the Proceedings of ... ) that showed when ibrutinib (IMBRUVICA ® ) ... inhibitor), suppression of tumor growth was enhanced suggesting ... certain hematologic cancers and solid tumors with the ...
(Date:2/27/2015)... Feb. 27, 2015 Isis Pharmaceuticals, Inc. (Nasdaq: ... both its pro forma net operating loss (NOL) guidance ... strong financial position.  Isis, significantly improved financial results were ... million in payments the Company received from its partners.  ... was a nearly 60% improvement over its 2013 NOL ...
Breaking Medicine Technology:Survey Published in AMCP's JMCP Finds Pharmacists Are Most Confident Substituting Interchangeable Biosimilars for Brand Biologics When Products Share Nonproprietary Name 2In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 2In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 3In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 4In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 5In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 6In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 7In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 8In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 9Isis Reports Financial Results and Highlights for 2014 2Isis Reports Financial Results and Highlights for 2014 3Isis Reports Financial Results and Highlights for 2014 4Isis Reports Financial Results and Highlights for 2014 5Isis Reports Financial Results and Highlights for 2014 6Isis Reports Financial Results and Highlights for 2014 7Isis Reports Financial Results and Highlights for 2014 8Isis Reports Financial Results and Highlights for 2014 9Isis Reports Financial Results and Highlights for 2014 10Isis Reports Financial Results and Highlights for 2014 11Isis Reports Financial Results and Highlights for 2014 12Isis Reports Financial Results and Highlights for 2014 13Isis Reports Financial Results and Highlights for 2014 14Isis Reports Financial Results and Highlights for 2014 15Isis Reports Financial Results and Highlights for 2014 16Isis Reports Financial Results and Highlights for 2014 17
... DALLAS, Oct. 15 /PRNewswire-FirstCall/ -- ACCESS ... provided an update on its European commercial launch of ... debilitating side effect of radiation treatment and chemotherapy. ... five European countries, having been granted the CE mak ...
... Pharmaceuticals, Inc. announced today that new data confirm that ... of fat absorption in children aged 7-11 years who ... (CF). EPI is a condition resulting from a deficiency ... are necessary to digest nutrients in food. CREON® has ...
Cached Medicine Technology:Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians Feedback 2Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians Feedback 3Access Pharmaceuticals Provides Update on MuGard Commercial Launch and First European Clinicians Feedback 4CREON(R) (pancrelipase) Delayed-Release Capsules Improves Absorption of Fat in Young Children With Cystic Fibrosis 2CREON(R) (pancrelipase) Delayed-Release Capsules Improves Absorption of Fat in Young Children With Cystic Fibrosis 3CREON(R) (pancrelipase) Delayed-Release Capsules Improves Absorption of Fat in Young Children With Cystic Fibrosis 4CREON(R) (pancrelipase) Delayed-Release Capsules Improves Absorption of Fat in Young Children With Cystic Fibrosis 5CREON(R) (pancrelipase) Delayed-Release Capsules Improves Absorption of Fat in Young Children With Cystic Fibrosis 6
... flexible liquid handling system ... functionality of up to ... on the same worksurface. ... smart solutions for targeted ...
... award winning practically new Dade DAC II automatic ... automatic cell washer. The Dade (Baxter) Dac II ... primarily used to process samples for immunohematolgy tests. ... bench-top multipurpose instrument , Performs cell washing and ...
... a simple click of the mouse ... mouse cursor to the desired position ... slide and the magnified image is ... Interface (GUI) enables one-click operation of ...
... floor-standing centrifuge. Mobile space saver, very ... of accessories, analog controls, large bright ... (JOUAN patented pendulum system), guard barrier, ... limitation, rugged motor, tough steel casing ...
Medicine Products: